header.html

An official website of the European Union How do you know?      
European Commission logo

handle.jsp

cover
Background Breast cancer is one of the most common cancers affecting women worldwide, with the number of new cases predicted to increase to over three million and the number of deaths to one million per year, by 2040. To prevent breast cancer, there is now increasing demand for personalization of breast cancer screening based on risk levels, considering the individual characteristics of the women. Methods We performed a synthesis of the evidence available for risk assessment models (RAMs) to predict breast cancer. Results We identified nine systematic reviews that evaluated risk assessment models for breast cancer. Across the systematic reviews, we identified five original models and 13 modifications that were externally validated. The evidence from primary studies that includes deep learning prediction models is limited. Most of the studies only report internal validation results in samples with small number of events. Conclusions Results from ongoing clinical trials and cohort studies will likely provide relevant empirical data. In addition, research on genotyping and, as shown in encouraging preliminary reports, research on deep-learning algorithm-based prediction models based on mammographic screening images should further improve the estimation of individual breast cancer risk.
2024-09-24
Publications Office of the European Union
JRC138682
978-92-68-20459-7 (online),    978-92-68-20576-1 (print),   
1831-9424 (online),    1018-5593 (print),   
EUR 40013,    OP KJ-01-24-001-EN-N (online),    OP KJ-01-24-001-EN-C (print),   
https://publications.jrc.ec.europa.eu/repository/handle/JRC138682,   
10.2760/0359784 (online),    10.2760/2311237 (print),   
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 

footer.html